| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 May 2025 | 26 Apr 2025 |
| Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve the Audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and year ended March 31 2025 together with the Auditors Reports thereon by the Statutory Auditors of the Company; and recommend dividend if any on the equity shares of the Company for the financial year 2024-25 Outcome of Board Meeting held on May 12, 2025 recommended dividend of Rs. 3.50/- (Rupees Three and Fifty paise only) per equity share of Re.1/- each for the financial year 2024-25, subject to the approval of shareholders at the ensuing Annual General Meeting (AGM). Appointment of Secretarial Auditor (As Per BSE Announcement Dated on :12.05.2025) | ||
| Board Meeting | 25 Mar 2025 | 25 Mar 2025 |
| Approval for sale of Companys entire equity stake in Jyothy Kallol Bangladesh Limited. | ||
| Board Meeting | 31 Jan 2025 | 15 Jan 2025 |
| Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider and approve Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and nine months ended December 31, 2024, with limited review thereon by the Statutory Auditors of the Company. Attached are the unaudited Financial Results for the Quarter and Nine Months ended December 31, 2024 (As Per BSE Announcement dated on 31.01.2025) | ||
| Board Meeting | 12 Nov 2024 | 4 Nov 2024 |
| Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and half year ended September 30 2024 with limited review thereon by the Statutory Auditors of the Company Unaudited Financial Results For The quarter and half year ended September 30, 2024 (As Per BSE Announcement Dated on 12.11.2024) | ||
| Board Meeting | 25 Jul 2024 | 9 Jul 2024 |
| Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2024 inter alia to consider and approve the Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter ended June 30 2024 with limited review thereon by the Statutory Auditors of the Company Outcome of Board Meeting held on July 25, 2024 (As per BSE Announcement Dated on 25/07/2024) | ||
Operating performance was marginally improved with EBITDA increasing by 3.1% to ₹112 crore in Q4 FY25 from ₹108.5 crore in the same quarter last year
The sale was approved by the Board of Directors at a meeting held on March 25, 2025. Post sale, JKBL ceases to be a subsidiary of Jyothy Labs.
Operating EBITDA grew by 2.3% YoY, reaching ₹138.5 Crore, up from ₹135.4 Crore in the previous year’s Q2.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
